IL6 and colitis: These anti-inflammatory and antioxidant effects have been similarly reported in various pathological models, including colitis [53], ischemia–reperfusion injury [20], and diabetes [54], where MB administration reduced TNF-α, IL-1β, IL-6, and CRP levels, suppressed MPO and MDA, and enhanced SOD activity.